Status:
COMPLETED
Bioindicators Associated With Sarcopenia Before and After Intensive Lifestyle Intervention
Lead Sponsor:
Lijun Yang
Collaborating Sponsors:
Suzhou Municipal Hospital
Conditions:
Sarcopenia
Eligibility:
All Genders
65-90 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to explore whether the bioindicators of body composition, nutrition-related indicators (lymphocytes, albumin), lipids, and thyroid hormones are associated with sarco...
Eligibility Criteria
Inclusion
- 1\) Resident elderly aged 65-90 years old in the district.
- 2\) Voluntary participation in the trial and signing the informed consent form.
Exclusion
- 1\) People with systemic severe diseases, organ failure, malignant tumors, neuromuscular degenerative diseases, or active weight loss.
- 2\) People with cognitive impairment, incapacitation, or severe mental illnesses who cannot cooperate with the test.
- 3\) People with cardiac pacemakers and artificial joint implantation or others who cannot undergo the BIA test.
- 4\) People with severe cardiorespiratory dysfunction and physical disabilities who cannot complete the exercise training.
- 5\) Incomplete data, refusal to participate in the survey, body composition analysis, and blood collection.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 2 2022
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT06128577
Start Date
March 1 2022
End Date
August 2 2022
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suzhou Municipal Hospital
Suzhou, Jiangsu, China, 215000